Combatting a Silent Epidemic: Best Practices for Overcoming the Challenges of NAFLD Clinical Trials

Read more

As our understanding of Non-Alcoholic Fatty Liver Disease (NAFLD) and diagnostic approaches has evolved, so too have the best practices to be considered when implementing a NAFLD clinical drug trial. This article discusses the current challenges confronting NAFLD clinical trials, as well as ‘best practices’ to be aware of when designing such trials.


Executive Director, Medical Affairs & Therapeutic Area Lead, Digestive Diseases

Copyright: International Clinical Trials, Winter 2023, pages 12-15. © Samedan Ltd

Want to learn more about Worldwide Clinical Trials?